Showing results (4541-4550 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|June 24, 2014
Medications not intended for treatment of dyslipidemias and with a variable effect on lipidsThomas F Whayne, Debabrata MukherjeeCurrent Pharmaceutical Design|June 24, 2014
Dyslipidaemia related to insulin resistance and cardiovascular disease in South Asian and West African populationsMfon Ewang-Emukowhate, Dilinika Perera, Anthony S D M WierzbickiCurrent Pharmaceutical Design|July 28, 2012
Insulin resistance and polycystic ovary syndrome through lifeEvanthia Diamanti-Kandarakis, Poli Mara Spritzer, Teresa Sir-Petermann, et al.Current Pharmaceutical Design|October 25, 2012
Development of small molecule HIV-1 fusion inhibitors: linking biology to chemistryFusako Miyamoto, Eiichi N KodamaCurrent Pharmaceutical Design|October 25, 2012
The current status and challenges in the development of fusion inhibitors as therapeutics for HIV-1 infectionJian Jun Tan, Xue Ting Ma, Chang Liu, et al.Current Pharmaceutical Design|October 25, 2012
Periodontitis and redox status: a reviewLuigi Nibali, Nikos DonosCurrent Pharmaceutical Design|October 25, 2012
Regulation of autophagy in oxygen-dependent cellular stressStefan W Ryter, Augustine M K ChoiCurrent Pharmaceutical Design|October 25, 2012
Reactive oxygen and nitrogen species in the renal ischemia/reperfusion injuryFrancisca Rodriguez, Barbara Bonacasa, Francisco J Fenoy, et al.Current Pharmaceutical Design|October 25, 2012
Ellagic acid: cytodifferentiating and antiproliferative effects in human prostatic cancer cell linesLuca Vanella, Ignazio Barbagallo, Rosaria Acquaviva, et al.Pageof 1,008